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Summary
The physiology and timing of gill muscle potentiation
filaments. Potentiation was inhibited by ODQ, which
were explored in the clam Mercenaria mercenaria. When
inhibits soluble guanylate cyclase (sGC), and it was
isolated demibranchs were exposed twice (with an
mimicked by dibutyryl-cGMP, an analog of cyclic GMP
intervening wash) to the same concentration of 5(cGMP). Moreover, potentiation was inhibited by the
hydroxytryptamine, the second contraction was larger
protein kinase G (PKG) inhibitor Rp-8-CPT-cGMPS.
than the first. This potentiation was seasonal: it was
During the season of potentiation, immunoreactive sGC
present from November through June, and absent from
was concentrated in the gill muscles and the gill filament
July through October. Potentiation was not affected by the
epithelium; but during the off-season, immunoreactive
geographic origin of the clams, nor by their acclimation
sGC was found in the gill filament epithelium. These data
temperature. Potentiation was inhibited by the nitric oxide
suggest that the potentiation of gill muscle is mediated by
synthase (NOS) inhibitor L-NAME and mimicked by the
a NO/cGMP/PKG signaling pathway.
nitric oxide (NO) donor DEANO. During the season of
potentiation, immunoreactive NOS appeared in the gill
muscles and the gill filament epithelium, but during the
Key words: clam, Mercenaria mercenaria, gill, muscle, nitric oxide
(NO), potentiation, season, signaling pathway.
off-season, the enzyme occurred at the base of the gill

Introduction
Because most bivalve molluscs are filter feeders, the gills
serve dual functions, feeding and respiration, and are thus very
complex organs. For several years, we have been investigating
the neural control of the cilia and musculature in the gills of
the quahog Mercenaria mercenaria (Gainey et al., 1999a,
2003). In this report, we consider a long-term potentiation
of the gill musculature that is induced seasonally by 5hydroxytryptamine (5HT) and is mediated by a nitric
oxide/cyclic GMP/protein kinase G (NO/cGMP/PK-G)
pathway.
In addition to being eulamellibranch, the gills of Mercenaria
are also plicate (Kellogg, 1892). That is, adjacent filaments are
connected to each other by interfilament tissue junctions, while
the ascending and descending filaments within each
demibranch are connected at intervals by interlamellar tissue
junctions (i.e. the septa), an arrangement that produces the
plicae and the water tubes (Fig.·1). Water flow though the gill
is determined by both the rate of beat of the lateral cilia and
the geometry of the gill, which includes the spacing of the
filaments, the shape of the plicae, and the diameter of the water
tubes. These geometric parameters are controlled by the
contractile state of the gill musculature, which consists of two
distinct domains: the longitudinal/dorso–ventral muscles, and
the water tube muscles. In particular, contraction of the

longitudinal muscles reduces the length of the gill and narrows
the spacing between adjacent filaments, whereas contraction of
the water tube muscles constricts the diameter of the water
tubes and changes the shape of the plicae (Gainey et al., 2003).
We recently demonstrated a complex network of
dopaminergic and serotonergic fibers associated with the
musculature in the gill and proposed, on pharmacological
evidence, that 5HT is the excitatory and ACh the inhibitory
transmitter to those muscles (Gainey et al., 2003). During that
investigation, we discovered, quite by accident, that if a gill
was exposed twice to the same concentration of 5HT (with a
wash between doses), then the second contraction was
typically larger than the first. We hypothesized that this
potentiation might be mediated by NO because, although this
molecule is best known as a gaseous, inter-neuronal signaling
agent, it is also synthesized in muscle, where it modulates
contractility.
In vertebrates, NO modulates the activity of the three classes
of muscle: cardiac, skeletal and smooth, but its effects in these
muscles are complex and variable (for reviews on cardiac
muscle, see Brady et al., 1993; Hare and Stammler, 1999; Ohba
and Kawata, 1999; Petroff et al., 2001; Satoh and Naoki, 2001;
Reading and Barclay, 2002; for skeletal muscle, see Marechal
and Gailly, 1999; Stamler and Meissner, 2001; for smooth
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Fig.·1. Diagrammatic anatomy of Mercenaria mercenaria (adapted
from Gainey et al., 2003). (A) Cross section of a clam. (B) Cross
sections through portions of relaxed and contracted demibranchs cut
in an anterior–posterior direction, i.e. in and out of the plane of the
page with respect to the top figure. (C) Details of a water tube: with
the musculature relaxed (left), and contracted (right). The water tube
muscles are within the walls of the horizontal blood vessels, the
vessels are not shown here. The longitudinal muscles lie between the
water tube muscles (and the horizontal blood vessels) and the base of
the gill filaments. bv, blood vessel; gf, gill filament; lm, longitudinal
muscle; s, septum; wtm, water tube muscle.

muscle, see Buchwalow et al., 2002). Nitric oxide synthase
(NOS) has also been demonstrated in all classes of molluscs
except Monoplacophora and Aplacophora (reviewed by Moroz
and Gillette, 1995; Untch et al., 1999), and NO relaxes vascular

muscle in the cuttlefish Sepia officinalis (Schipp and Gebaure,
1999). More to the point, in Mercenaria, NOS has been
localized using the NADPH-diaphorase technique to such nonneuronal tissue as the gill muscles and the cilia of the gut
(Untch et al., 1999). Moreover, a small fragment of a gene
encoding NOS (~129·bp) has been cloned from Mercenaria;
the amino acid sequence is 71% similar to the calmodulin
binding site of human neuronal NOS (L. L. Moroz and B.
Untch, University of Florida, personal communication).
The mechanisms whereby NO exerts its effects within cells
fall into two broad categories: S-nitrosylation of effector
proteins, and stimulation of soluble guanylate cyclase (sGC)
leading to an increase in the concentration of cGMP (see
reviews by Denninger and Marletta, 1999; Jaffrey et al., 2001).
Within invertebrate neurons and muscles, however, signaling
appears to be confined to the cGMP pathway (Aplysia
californica neurons, Koh and Jacklet, 1999; Asterias rubens
muscle, Elphick and Melarange, 2001; Idotea baltica muscle,
Erxleben and Hermann, 2001; Sepia officinalis muscle, Schipp
and Gebauer, 1999).
To test our hypothesis about the 5HT-induced potentiation
of gill musculature, we: (1) studied the time course and
seasonal occurrence of this potentiation; (2) investigated the
pharmacology of agents that act at various stages in the
NO/cGMP/PK-G signaling pathway; (3) determined the
immunohistochemical distribution of NOS and sGC.
Preliminary results of this study were presented to the Society
for Integrative and Comparative Biology and the Society for
Neuroscience (Gainey et al., 1999b; Greenberg et al., 2000).
Materials and methods
Animals
Quahogs Mercenaria mercenaria L. that had been dug from
various locales along the northeast Atlantic coast (but mostly
from Cape Cod), were purchased from Harbor Fish Market and
Hannaford Brothers in Portland, Maine, USA. In the text, we
refer to these animals as northern clams. Quahogs were also
dug from Salt Run, a narrow tidal embayment, in St.
Augustine, Florida. In the text, we refer to these animals as
Florida clams. Unless otherwise noted in the text, the animals
were held at 10°C on a 12·h:12·h light:dark cycle. All animals
were held in 30‰ natural seawater. Individuals were held a
minimum of 3 days before use.
Gill preparation and apparatus
Gills were dissected away from the body wall, separated into
demibranchs, and the main trunks of the branchial nerves were
removed. Muscular contractions were recorded as changes in
the length of the anterior–posterior axis of the isolated
demibranchs.
Contractions of the branchial muscles were recorded in
either of two ways. (1) Isolated demibranchs were suspended
in organ baths and attached with thread to isometric force
transducers [Grass FT03 (Grass Instruments Division, AstroMed, Inc., West Warwick, RI, USA) and UFI 1030 (UFI,
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Contraction ratios
Each of a clam’s four demibranchs was isolated, suspended
in an organ bath and attached to a force transducer. After
15·min of relaxation, each of the demibranchs was exposed to
2×10–5·mol·l–1 5HT. After the resulting contractions had
leveled off, the baths were flushed and a variable amount of
time, dependent upon the specific experiment, elapsed before
reapplying the same dose of 5HT. The experimental results are
expressed as the ratio between the second and first contractions
from the same demibranch and are thus internal contraction
ratios (Fig.·2).
In certain experiments, designed to examine the
pharmacology of potentiation, it was necessary to pretreat a
demibranch with an agent before exposure to 5HT. In this
experimental design, one of a pair of inner or outer
demibranchs was exposed to an agent (the treated demibranch)
while the control was untreated. After a predetermined time,
both demibranchs of the pair were exposed to only one dose
of 5HT. An external contraction ratio was constructed by
dividing the response of the treated demibranch (as a

Morro Bay, CA, USA)] equipped with springs; the resulting
contractions were therefore semi-isotonic. The transducers
were interfaced to DA 100 amplifiers and an MP100 analogto-digital converter (Biopac, Santa Barbara, CA, USA). (2)
In one set of experiments, ultratrasonic crystal transceivers
(Sonometrics, London, Ontario, Canada) were tied to the
ends of demibranchs with thread. One end of the demibranch
was pinned to a piece of rubber band that was glued with
rubber cement to the bottom of a plastic Petri dish (4.7·cm
diameter); the Petri dishes were placed on a cooling plate to
maintain temperature. Under these conditions, the muscles
were unrestrained and contracted against virtually no external
load; thus, a single demibranch could be used for an entire
dose–response experiment. The isotonic contractions were
measured with a digital ultrasonic measurement system
(TRX series 8; Sonometrics). In both cases, the magnitude
of the contractions was measured with AcqKnowledge
version 3.5 (Biopac Systems). All experiments were carried
out at 10°C in aerated artificial seawater (ASW; Welsh et al.,
1968).
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Fig.·2. Experimental designs used to construct internal and external contraction ratios. In general, internal contraction ratios were used to
ascertain elements of the signaling pathway leading to potentiation e.g. enzyme inhibitors that block potentiation, whereas external contraction
ratios were used to ascertain elements that mimic potentiation e.g. DEANO, and to determine if any of the enzymes are involved in the initial
response to 5HT. Traces represent contraction of the gill muscles in response to 5-hydroxytryptamine (5HT; upward arrows) followed by
flushing of the organ bath and relaxation of the muscle (downward arrows). The enzymes inferred for the signaling pathway are boxed. –,
enzyme inhibitors; +, stimulators; hc, height of control contraction; ht, height of treatment contraction; nNOS, neuronal nitric oxide synthase;
NO, nitric oxide; L-NAME, a NOS inhibitor; sGC, soluble guanylate cyclase; ODQ, a sGC inhibitor; cGMP, cyclic GMP; PKG, protein kinase
G; Rp-8-CPT-cGMPS, a PK-G inihibitor; DEANO, an NO generator; db-cGMP, dibutyryl cGMP, a cell permeable cGMP analog.
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percentage of its initial length) by the response of the control
demibranch (again as a percentage of its initial length, Fig.·2).
The internal contraction ratios of untreated controls were
analyzed using a Kolmogorov–Smirnov one-sample test,
which revealed that these data were not normally distributed
(P<0.001, two-tailed, N=139). Both internal and external
contraction ratios were therefore normalized by a logarithmic
transformation. The normality of this transformation was
checked as above (Kolmogorov–Smirnov; P=0.614). The lntransformed ratios were tested against a mean of 0 (since
ln1=0) with a one-sample t-test. This is mathematically
equivalent to a paired t-test because the contractions used to
construct the ratios were either from the same demibranch or
the same clam in the case of external contraction ratios.
Although the statistical tests were performed on the lntransformed data, for clarity in the Results, data in tables and
figures are presented untransformed. Depending upon the
specific experiment, the P-values reported for these tests are
either two-tailed or one-tailed probabilities and are noted as
such in the results; P-values <0.05 were considered significant.
Exposure times to modulatory agents
The appropriate times for exposure to various agents were
determined from the literature and by trial and error at an initial
concentration 10–5·mol·l–1. The specific times are noted in the
Results.
Gill anatomy
Isolated demibranchs were allowed to relax overnight at 5°C
in isotonic MgCl2 in ASW (7.6% MgCl2 in distilled water
added to an equal volume of ASW). The relaxed demibranchs
were then pinned to a small Petri dish, the bottom of which
was coated with Sylgard. Demibranchs were fixed overnight in
4% paraformaldehyde in phosphate-buffered saline
(0.01·mol·l–1 sodium phosphate, 530·mmol·l–1 NaCl, pH·7.3;
PBS). The fixative was prepared as described in Gainey et al.
(1999a). Because mammalian antibodies were used for the
immunohistochemistry, subsequent rinses and solutions were
made in mammalian PBS (mPBS; 0.1·mol·l–1 sodium
phosphate, 140·mmol·l–1 NaCl, pH·7.3).
After fixation and a 15·min rinse in mPBS, 12·µm cryostat
sections were prepared. The demibranchs were placed in a
solution of 30% sucrose/mPBS overnight at 5°C. Pieces of
demibranch were then placed in Tissue Tek OCT, frozen and
sectioned. Sections were placed on gel-coated slides and stored
at –20°C until used.
After fixation and three 15·min rinses in mPBS, 100·µm
vibratome sections were prepared. Pieces of demibranch were
placed in a plastic mold and covered with 12% Type A pigskin
gelatin in mPBS, which had been heated to 50°C. The tissue
was sectioned with the vibratome after the gelatin had cooled.
The sections were placed on gel-coated slides and heated
briefly at 50°C to melt the excess gelatin.
Both cryostat and vibratome sections were processed at 5°C
and all of the steps are described in detail in Gainey et al. (2003).
Muscles were visualized with phalloidin conjugated to the

fluorescent probe Alexa Fluor 488 (Molecular Probes, Eugene,
OR, USA) at a concentration of 1·unit/100·µl of mPBS. The
phalloidin was added to the tissues at the same time as the
secondary antibody.
The primary antibody to NOS was polyclonal, raised in
rabbit, and affinity purified (Universal NOS antibody, product
number N-217, Sigma-Aldrich, St Louis, MO, USA). The
antibody was raised to the synthetic peptide DQKRYHEDIFG,
which comprises amino acid residues 1113–1122 of mouse
NOS, with an added N-terminal aspartyl residue. Since the
antigenic undecapeptide was conjugated to keyhole limpet
hemocyanin (KLH) through this N-terminal aspartic acid, and
since heterodont clams do not contain hemocyanin, the 5–6
amino acid residues at the free C-terminal of the peptide
determined the immunoreactivity of the antibody. When we
used BLAST to search in Mollusca for protein sequences with
alignments similar to that of the antigenic peptide, the top
two results were NOS sequences from Aplysia californica
(accession number AAK83069) and Lymnaea stagnalis
(accession number O61039). Both proteins include an 11residue sequence with the C-terminal sequence –HEDIFG, in
the same general location as those in the mouse. Since this
hexapeptide is conserved in mouse and two gastropods, and
since it is almost certainly the epitope for the universal NOS
antibody, we conclude that, in clam gills, the antibody is also
detecting NOS. This conclusion was supported by our
observation that clam gills subjected to the NADPHdiaphorase technique showed staining comparable to that seen
in gills processed with the antibody (L. L. Moroz and B. Untch,
unpublished observations). A 1/100 dilution of the antibody
with mPBS was used for the images in Fig.·10.
The primary antibody to soluble guanylate cyclase (sGC)
was a rabbit polyclonal raised to two antigenic peptides:
EQARAQDGLKKRLGKLKAT (human α1 residues 414–432)
and EDFYEDLDRFEENGTQDSR (rat β1 residues 188-207);
the peptides were both conjugated to KLH (product number
160890; Cayman Chemical, Ann Arbor, MI, USA). A BLAST
search revealed that the antigenic α peptide is similar to α
subunit sGC sequences in both Drosophila and Manduca; there

0.5 mm
5 min

Fig.·3. Contractions of gill muscles in response to 2×10–5·mol·l–1
5HT (applied at the upward arrows). The response to each dose of
5HT was terminated by flushing the organ bath (at downward
arrows). 1·h elapsed between the flush and the addition of the second
dose of 5HT.
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are no sequence data of sGC in molluscs. A 1/100 dilution of
the antibody with mPBS was used for the images in Fig.·10.
The secondary antibody in both instances was a goat antirabbit (IgG) conjugated to Alexa Fluor 594 (Molecular
Probes); the antibody was used at a 1/200 dilution in mPBS.
Negative controls were made by omitting the primary
antibodies from one slide in each series of preparations.
Fluorescent images were made with a Nikon Eclipse TE200
or a Leica DMLB microscope equipped with a Spot RT digital
color camera (Diagnostic Instruments, St Sterling Heights, MI,
USA). Images were prepared for publication with Adobe
Photoshop.
Dose-dependent effects
All contractions, measured in mm, were expressed as a
percentage of the initial length of each demibranch. Regression
lines were fitted with a logistic function of the form:
response=α/1+exp[β0+β1×log(agonist)], where α is the
asymptotic value of the maximal contraction, and β0 and β1 are
intercept and slope parameters, respectively. Initially, all three
parameters were estimated using non-linear regression (Systat,
v. 9 and 10); later α was fixed in the model, reducing the error
estimates of the remaining parameters. The concentrations of
agonist giving half-maximal responses (EC50) were estimated
according to the following formula: EC50=10(–β0/β1).
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Fig.·4. Effect on the internal contraction ratio of the length of time
between the first flush of the organ bath and the addition of the
second dose of 2×10–5·mol·l–1 5HT. Note the scale break between 3
and 24·h. Values are means ± 1 S.E.M., N= 18 (15·min), 98 (30·min),
41 (60·min), 8 (2·h), 4 (3·h), 15 (24·h).
4.5

Duration
In our initial experiments, leading to the discovery of
potentiation, the period between the end of the first dose of
5HT (flushing of the organ baths) and the addition of the
second dose was 1·h. To study whether the potentiation was
time dependent, we varied this period between 15·min and 24·h
(Fig.·4). The mean internal contraction ratios, as a measure of
potentiation, ranged from a high of 2.45±0.69 (±S.E.M.; N=8)
at 2·h to a low of 2.00±0.45 (N=15) at 24·h; but ANOVA
revealed that there were no significant differences amongst any
of the times (F5,178=0.28; P=0.92). These data were collected
in the winter.
Seasonal effects
From data collected over 5 years, monthly mean internal
contraction ratios were calculated, and ranged from a high of
2.94±0.65 (mean ± S.E.M.; N=23) in February to a low of
0.88±0.12 (N=30) in October. Moreover, when these monthly
means were plotted, a clear seasonal component to potentiation
was revealed (Fig.·5). From November through June, the

4.0
3.5
Internal contraction ratio

Results
Potentiation
Previously, we reported that the second contraction of
demibranchs in response to 2×10–5·mol·l–1 5HT is larger than
the initial contraction, i.e. the ratio of the second contraction
to the first is significantly greater than 1 (Gainey et al., 2003).
In physiological terms, the first dose of 5HT potentiates the
response of the muscle to the second dose (Fig.·3).

3.0
2.5
2.0
1.5
1.0
0.5
0

Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
Month

Fig.·5. Monthly variation in a five-year set of mean internal
contraction ratios in response to 2×10–5·mol·l–1 5HT. Each
demibranch was exposed twice to 5HT with a 30·min or 1·h period
of relaxation between exposures; the internal contraction ratio is the
second response/initial response for each demibranch. Values are
means ± 1 S.E.M., N=14 (Jan), 23 (Feb), 51 (Mar), 35 (Apr), 39
(May), 46 (June), 80 (July), 39 (Aug), 32 (Sept), 30 (Oct), 17 (Nov),
13 (Dec).

period of potentiation, all of the mean internal contraction
ratios were equal to each other (F7,226=1.845; P=0.08) and
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significantly greater than 1 (one-tailed P<0.001). From July
through October, the season of no potentiation, the mean
internal contraction ratios were again equal to each other
(F3,177=2.36; P=0.06), but they were not different from 1 (twotailed, P=0.07).
Geographic effects
Because the clams used in our experiments all came from
the northeastern USA, we wondered if geographical origin
affected potentiation. To answer this question, we compared
the internal contraction ratios of northern clams to those of
Florida clams; comparisons were made in July and August,
when potentiation was absent, and in March, when potentiation
was present. In neither case, was there a statistical difference
between northern and Florida clams (Table·1).
Acclimation temperature and geography
In the previous experiments, the northern clams were
maintained at 10°C while the Florida clams were kept at 20°C,
so we tested whether the acclimation temperature affected the
internal contraction ratios. In March, we acclimated clams
from Maine and Florida to temperatures of both 10°C and 20°C
for 1 week and compared the mean internal contraction ratios
using a two-way ANOVA. Neither geographic region nor
Table·1. Comparison of mean internal contraction ratios
(ICR) between northern and Florida clams in July/August
(summer) and March (winter)
Season

Region

ICR

S.E.M.

Summer
Summer
Winter
Winter

North
Florida
North
Florida

1.17
1.37
2.51
2.32

0.11
0.20
0.39
0.47

N
34
18
16
12

P
0.17
0.52

Northern clams were acclimated to 10°C and Florida clams to
20°C for both seasons.
S.E.M., standard error of mean; P = two-tailed probability.

Table·2. The effects of geographic origin and acclimation
temperature on the mean internal contraction ratios

Region

Month

Florida

March

Maine

March

Massachusetts

September

Acclimation
temperature
(°C)

ICR

S.E.M.

N

20
10
20
10
20
10

2.32
2.57
2.06
2.51
1.12
1.02

0.47
0.65
0.24
0.39
0.14
0.12

12
11
12
16
21
19

ICR, mean internal contraction ratio.
For the clams tested in March, the ICRs are equal – see text for P
values from two-way ANOVA.
For the clams tested in September, the ICRs are also equal to each
other.
S.E.M., standard error of mean; two-tailed P=0.11.

acclimation temperature was significant (F1,47=0.1, 0.17;
P=0.76, 0.68, respectively; Table·2). Moreover, we acclimated
clams from Massachusetts to temperatures of 10°C and 20°C
for 1 week in September and compared the internal contraction
ratios, and again there was no significant difference (two-tailed
P=0.11; Table·2).
Nitric oxide mediates potentiation
To test if potentiation was mediated by nitric oxide
(NO), we performed the following experiments and
immunohistochemical observations. (1) We inhibited nitric
oxide synthase (NOS) with L-NAME (nitro-L-arginine methyl
ester); (2) pretreated gills with the NO donor DEANO
(diethylamine/nitric oxide complex); and (3) prepared gill
sections were exposed to the universal NOS antibody.
Inhibition of NOS
In May, when potentiation was present, we exposed
demibranchs to the NOS inhibitor L-NAME for 15·min before
the second exposure to 5HT. Potentiation was abolished at LNAME concentrations of 10–6, 10–5 and 10–4·mol·l–1, and none
of these mean internal contraction ratios were significantly
different from 1 (Fig.·6). At lower concentrations of L-NAME
(10–8, 10–7·mol·l–1), the mean internal contraction ratios were
not significantly different from those of control clams (twotailed P=0.14 at 10–8·mol·l–1; P=0.46 at 10–7·mol·l–1; internal
contraction ratio of controls=2.72±0.44, mean ± S.E.M.; N=15).
As an additional control, gills were exposed to the inactive
enantiomer D-NAME, at 10–4·mol·l–1; the internal contraction
ratio was 2.04±0.32 (mean ± S.E.M., N=5), which was not
significantly different from that of untreated controls (twotailed P=0.48) (not shown).
In the previous experiments, potentiation was studied at
2×10–5·mol·l–1 5HT. But is the magnitude of potentiation
dependent upon the concentration of 5HT? To answer this
question, we used paired demibranchs from the same clams:
one demibranch was exposed to 10–5·mol·l–1 L-NAME to
block potentiation, then both demibranchs were exposed
to increasing concentrations of 5HT. The responses were
measured with ultrasound, which minimized fatigue, thus a
single demibranch could be used for an entire dose–response
curve. The control demibranchs would show the effects of both
5HT and NO, because they were exposed to multiple,
increasing doses of 5HT; while the demibranchs pre-treated
with L-NAME would show only the effects of 5HT. At 5HT
concentrations below 5×10–6·mol·l–1, the responses of both
treatment and control demibranchs were indistinguishable. At
concentrations of 5×10–6·mol·l–1 5HT and above, the data and
the regression lines diverge. The data and the curve for the
demibranchs treated with L-NAME lie below those of the
control demibranchs, and the statistically significant difference
between the control and treatment lines is the contribution of
NO to the effects of 5HT (F1,52=100; P<0.001; Fig.·7). Thus,
the amount of potentiation is dependent upon the dose of 5HT.
The two previous experiments suggest that the potentiation
of the second response to 5HT is mediated by NO. But does

Potentiation of clam gill muscle by nitric oxide 3513
40

A

Control
35
L-NAME

Contraction (% of resting length)

0.5 mm
2 min

4.5

B

4.0

Internal contraction ratio

3.5
3.0

30
25
20
15
10
5

2.5

0

2.0

10–7

10–6.5 10–6

10–5.5 10–5 10–4.5
[5HT] (mol l–1)

10–4

10–3.5

1.5
1.0
0.5
0

10–8

10–7

10–6
10–5
[L-NAME] (mol l–1)

10–4

Fig.·6. The effect of L-NAME on internal contraction ratios.
(A) Contractions of the same demibranch in response to
2×10–5·mol·l–1 5HT (applied at the upward arrows). The response to
each dose of 5HT was terminated by flushing the organ bath
(downward arrows). L-NAME (10–4·mol·l–1) was applied for 15·min
before the second contraction. The resulting internal contraction ratio
was 0.92. (B) Various concentrations of L-NAME were applied to
isolated demibranchs for 15·min between their first and second
contractions in response to 2×10–5·mol·l–1 5HT Values are means ± 1
S.E.M., N=3 for all concentrations of L-NAME except 10–4·mol·l–1
where N=4.

NO also contribute to the initial response to 5HT? In January,
when potentiation was present, we pretreated one demibranch
of each pair with L-NAME for 15·min, and then exposed both
demibranchs to 2×10–5·mol·l–1 5HT. The resulting external
contraction ratios decreased markedly (Fig.·8); indeed, for 5HT
doses from 10–9 to 10–4·mol·l–1 the pooled external contraction
ratio=0.73±0.05 (mean ± S.E.M.; N=27) was significantly less
than 1 (one-tailed P<0.001), and these values were equal to
each other (F5,19=0.27; P=0.92). The external contraction ratio
at 10–10·mol·l–1 L-NAME was 0.96±0.10 (mean ± S.E.M.; N=3),
which was not significantly different from 1 (two-tailed
P=0.64). As a control, gills were pretreated with 10–5·mol·l–1
D-NAME, and the resulting external contraction ratios were not
significantly different from 1 (1.11±0.23, mean ± S.E.M.; N=6;
two-tailed P=0.87). Finally, we repeated the experiment in

Fig.·7. The effect of L-NAME on dose-dependent muscle contraction
(as a percentage of resting length) in response to 5HT. Treatment
demibranchs (solid circles/solid line) were exposed to 1×10–5·mol·l–1
L-NAME for 15·min, and then both treatment and control
demibranchs (open circle/broken line) were exposed to increasing
concentrations of 5HT. Data were recorded using ultrasound, which
allowed a single demibranch to be used for an entire dose–response
curve. Data consist of paired demibranchs (three treatments, three
controls) from three clams.

August, when potentiation was absent, with 10–5·mol·l–1 LNAME, and there was no significant effect upon the external
contraction ratio (1.10±0.19, mean ± S.E.M.; N=10; two-tailed
P=0.77; Fig.·8).
Effect of an NO donor
To confirm the results of the experiments with L-NAME, we
pretreated one of each pair of inner and outer demibranchs for
5·min with the NO donor DEANO. To retard the oxidation and
degassing of NO, all of the demibranchs were suspended in
degassed non-aerated seawater. Then we exposed all of the
demibranchs to 2×10–5·mol·l–1 5HT; thus, external contraction
ratios were calculated in this experiment. Nitric oxide, released
by DEANO, increased the external contraction ratios in a dosedependent manner (Fig.·9). The threshold of the response was
at 10–13·mol·l–1. At concentrations of DEANO greater than
10–10·mol·l–1, all of the external contraction ratios were
significantly greater than 1.
The experiments shown in Fig.·9 were performed in the late
fall, during the season of potentiation. In July, when
potentiation was absent, we repeated these experiments with
10–5·mol·l–1 DEANO, a concentration that had potentiated
contractions in the fall. The external contraction ratio (mean ±
S.E.M.) was 1.05±0.085; N=15), which was not significantly
different from a mean of 1 (two-tailed P=0.99); in other words,

External contraction ratio
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1.4

DEANO had no effect on 5HT induced contractions (Fig.·9,
open circle).

1.2

NOS immunohistochemistry
Our pharmacological data indicated that NOS should be
found in the gill. We examined thick sections (100·µm) of gills
removed from clams in November when potentiation is
present, and found immunoreactive (ir) NOS to be
concentrated in the longitudinal muscles, the muscles of the
blood vessel and septa, and the epithelium of the gill filaments
(Fig.·10A,B). Little ir-NOS was seen in the water tube
muscles. However, in July and August, when potentiation is
absent, thin and thick sections of gills showed NOS
concentrated only at the base of the gill filaments and in
varicose fibers adjacent to the gill muscle (Fig.·10C,D). The
enzyme was also unevenly distributed within the horizontal
blood vessels and subfilamentar tissues (Fig.·10C). Moreover,
the thin section (Fig.·10D) was made from Florida clams in
July, 2001, while the thick section (Fig.·10C) was made from
Massachusetts clams in August, 2002. Negative controls,
lacking the primary antibody, had low levels of background
fluorescence comparable to the tips of the filaments in
Fig.·10C.
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Fig.·8. The effect of L-NAME on mean external contraction ratios. In
this experiment, one demibranch was exposed to L-NAME for
15·min prior to exposure to 2×10–5·mol·l–1 5HT, while the control
demibranch was only exposed to 2×10–5·mol·l–1 5HT. The open
circle represents data collected in August, when potentiation is
absent. Values are means ± 1 S.E.M., N=3–10.
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Fig.·9. Mean external contraction ratios in response to an NO donor,
DEANO. The treatment demibranchs (numerator) were exposed first
to DEANO, and then to 2×10–5·mol·l–1 5HT, while the control
demibranchs (denominator) were only exposed to 2×10–5·mol·l–1
5HT. The open circle represents data collected in July, when
potentiation is absent. Values are means ± 1 S.E.M., N=3–15 at each
concentration of DEANO.

Signal transduction
Because NO exerts at least some of its effects by stimulating
soluble guanylate cyclase (sGC) and thereby increasing the
concentration of cGMP, we tested the effects of the membrane
permeable cGMP analog db-cGMP (dibutyryl cyclic GMP) on
branchial muscle contraction. The experimental design was
that used in the experiments with DEANO: one of each pair of
demibranchs was pretreated with db-cGMP for 15·min then
both demibranchs were then exposed to 2×10–5·mol·l–1 5HT,
and external contraction ratios calculated. db-cGMP increased
the external contraction ratios in a dose-dependent manner, and
the threshold was between 10–9 and 10–8·mol·l–1 (Fig.·11).
These experiments were performed in November and
December, during the season of potentiation.
To test further the hypothesis that NO augments branchial
muscle contraction by stimulating sGC, we exposed gills to
increasing concentrations of the sGC inhibitor ODQ
(oxadiasoloquinoxalin) for 60·min between the first and second
contractions. ODQ inhibited potentiation in a dose-dependent
manner (Fig.·12). The internal contraction ratio at 10–4·mol·l–1
ODQ was significantly lower than that of untreated controls
(one-sample P=0.019), but the ratio was still significantly
greater than 1(one-sample P<0.001).
Because we could not completely abolish potentiation with
ODQ in the previous experiment, we wondered if some of the
effects of NO were direct via S-nitrosylation of effector
proteins. Therefore, we pretreated one of each pair of
demibranchs with 10–6·mol·l–1 DEANO (a concentration
sufficient to elicit potentiation) and with increasing
concentrations of ODQ (at the time we performed this
experiment, we were not aware that NO potentiated the initial
contraction, hence we added the DEANO). Then we exposed
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Fig.·10. Seasonal variation in the
distribution of nitric oxide synthase
(NOS) and soluble guanylate cyclase
(sGC) in the gills of Mercenaria
mercenaria. (A) Thick (100·µm)
section; muscle fibers visualized with
green-fluorescing phalloidin. Muscle
is concentrated in the longitudinal
muscle (lm), which also sends
branches into each gill filament (gf);
muscle also occurs in the major blood
vessel (bv). (B) The same section as A
but visualized with a filter for red
fluorescence showing the distribution
of immunoreactive (ir) NOS. This
section was made in November (early
in the season of potentiation) in gills
from a Massachusetts clam. (C) Thick
section showing the distribution of
NOS in a gill taken from a
Massachusetts clam in August (no
potentiation) 2002. (D) Thin section
(12·µm) showing the distribution of
NOS in a gill taken from a Florida
clam in July (no potentiation) 2001.
Note the intense ir-NOS at the base of
the gill filaments and in varicose fibers
adjacent to the longitudinal muscle.
(E) Thick section of a gill in April
(potentiation) showing the distribution
of ir-sGC, which is concentrated in the
longitudinal and septal muscles and
the gill filaments. (F) Thick section of
a gill in August showing the
distribution of ir-sGC, which is
concentrated in the gill filaments and,
to a lesser extent, in the projections of
the longitudinal muscle in the gill
filaments. Note the lack of
fluorescence in the main body of the
longitudinal muscles. All thick
sections are 100·µm. hbv, horizontal
blood vessel; s, septum; sbv, septal
blood vessel; wt, water tube. Scale
bars, 50·µm (except for D, 25·µm).
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the treated and control gills to 2×10–5·mol·l–1 5HT. External
contraction ratios were calculated as usual. ODQ inhibited the
potentiation induced by DEANO (Fig.·13). The mean external
4.5
4.0

External contraction ratio
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Fig.·11. Mean external contraction ratios in response to the
membrane permeable cGMP analog, dibutyryl cGMP. The treatment
demibranchs (numerator) were exposed to dibutryl cGMP and then
to 2×10–5·mol·l–1 5HT, while the control demibranchs (denominator)
were only exposed to 2×10–5·mol·l–1 5HT. Values are means ± 1
S.E.M., N=8 for each concentration of dibutryl cGMP.

contraction ratios at 10–8, 10–7 and 10–6·mol·l–1 ODQ were
equal to each other (F2,12=0.137; P=0.87] and significantly
greater than 1 (one-tailed P=0.004). In contrast, the mean
external contraction ratios at 10–5 and 5×10–5·mol·l–1 ODQ
were not significantly different than 1 (two-tailed P=0.63 and
0.93, respectively). In summary, we could completely inhibit
NO-induced potentiation by inhibiting sGC.
To test whether cGMP affects potentiation directly, i.e. by
activating a cGMP-gated channel or by stimulating a protein
kinase G (PK-G), we treated gills with the PK-G inhibitor Rp8-CPT-cGMPS (10–5·mol·l–1; Rp-8-[(4-chlorophenyl)thio]guanosine 3′,5′-cyclic monophosphothioate) for 5·min
between the first and second contractions. The mean internal
contraction ratio for treated demibranchs was 1.06±0.15 (±
S.E.M.; N=12), which was significantly less than the control
contraction ratio of 2.01±0.51 (mean ± S.E.M.; N=9; one-tailed
P=0.02) (not shown).
sGC immunohistochemistry
Thick sections of demibranchs from clams in April showed
ir-sGC concentrated in the gill musculature and the gill
filament epithelium (Fig.·10E). In contrast, demibranchs taken
from clams in August, when potentiation was absent, had no
sGC in the main body of the longitudinal muscle, but the
enzyme was still present in the gill filament epithelium and in
branches of the longitudinal muscles running into the center of
each filament (Fig.·10F).
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Fig.·12. Mean internal contraction ratios in response to the
membrane permeable guanylate cyclase inhibitor ODQ. ODQ was
added between the first and second contractions in response to
2×10–5·mol·l–1 5HT. Values are means ± 1 S.E.M., N=6 for each
concentration of ODQ.

10–8

10–7

10–6

10–5

10–4
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Fig.·13. Mean external contraction ratios in response to the
membrane permeable guanylate cyclase inhibitor ODQ. Treatment
demibranchs (numerator) were exposed to 10–6·mol·l–1 DEANO and
varying concentrations of ODQ and then to 2×10–5·mol·l–1 5HT,
while the control demibranchs (denominator) were only exposed to
2×10–5·mol·l–1 5HT. Values are means ± 1 S.E.M., N=6–4 at each
concentration of ODQ.
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Fig.·15. Monthly dependence of the response to 2×10–5·mol·l–1 5HT.
Means are the response of demibranchs to an initial exposure to
2×10–5·mol·l–1 5HT. Values are means ± 1 S.E.M. Sample sizes are
the same as Fig.·4.

of these responses is not a sampling artifact. In particular, the
data for this month includes the responses of both northern
clams (% contraction=4.99; mean ± S.E.M.=0.63; N=30) and
Florida clams (% contraction=5.09±0.69, mean ± S.E.M.; N=24)
and they are clearly similar.
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Seasonal 5HT dose–response data
Because potentiation and the distributions of NOS and sGC
vary seasonally, we expected that a 5HT dose–response curve
produced with demibranchs from summer clams would lie to
the right of a curve produced with winter clams. That is, in the
summer (the season of no potentiation), muscles would be less
sensitive to 5HT. We therefore constructed a dose–response
curve to 5HT during July and August and compared it to one
previously, and fortuitously, produced during the winter
(Gainey et al., 2003). Unexpectedly, the dose–response curve
of summer gills lies to the left of that from winter gills, and
the regression lines are significantly different (F1,103=22;
P<0.001; Fig.·14). The EC50 for the line of summer is
3.8×10–5·mol·l–1 (95% CI=1.8×10–5 to 5.8×10–5·mol·l–1)
whereas, that for the winter is 1.1×10–4·mol·l–1 (95%
CI=4.0×10–5 to 1.8×10–4·mol·l–1).
Finally, using the data set for seasonal potentiation (Fig.·5),
we plotted, for each month, the mean response of the
demibranchs to their first exposure to 2×10–5·mol·l–1 5HT. The
mean response was measured as a fraction of the initial length
of the demibranch. One-way ANOVA revealed that the
mean monthly contractions were significantly different
(F11,338=11.29; P<0.001, Fig.·15). The responses are lowest in
February and rise incrementally to their maximum in July.
March, however, appears to be an outlier, because the mean
response in this month is as large as that in June. But close
inspection of the data from March suggests that the magnitude

10–7

10–6 10–5 10–4
[5HT] (mol l–1)

10–3

10–2

10–1

Fig.·14. Dose-dependent muscle contraction (as a percentage of the
resting length) in response to 5HT. Each point is the response of a
separate demibranch. Open circles/broken line: data collected in July
and August. Solid circle/solid line: data collected between December
and May.

Discussion
We have shown conclusively that the first application of
5HT to isolated gills potentiates the response of the gill
musculature to succeeding applications of the same dose of this
transmitter. Furthermore, this potentiation persists in vitro for
24·h. However, we have also discovered that the potentiation
is seasonal, being present from November through June, and
absent from July through October. We have also demonstrated
that the potentiation is abolished when NOS is inhibited and is
mimicked when the gill is treated with a nitric oxide donor.
These findings, together with pharmacological studies of signal
transduction, support our hypothesis that potentiation is
mediated by a NO/cGMP/PK-G signaling pathway. Finally,
the immunohistochemical localization of NOS and sGC varied
seasonally, being present within the longitudinal muscles
during the season of potentiation, and absent during the off
season.
Potentiation
Time course
The potentiation reported here is particularly striking
because it was maintained for up to 24·h in isolated gills, and
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the magnitudes of potentiation observed between 15·min and
24·h were equal. Similar potentiations, induced by prior
stimulation or related to the contraction history of the muscle,
have been observed in a variety of vertebrate muscles,
including skeletal (Rosenthal, 1969), cardiac (Hare and
Stamler, 1999) and airway smooth muscle (Gunst et al., 1993;
Meiss, 1997). Long-term potentiation of the buccal muscles of
the gastropod mollusc Aplysia has also been extensively
studied (Cropper et al., 1987a,b, 1990). But in most of these
cases, potentiation only lasts from seconds to minutes (see
previous references and Decostre et al., 2000; Pilarski and
Brechue, 2002), which is much shorter than the potentiation of
the gill muscle seen in the present work.
Seasonality, geography, and acclimation temperature
The seasonality of potentiation is another of its notable
aspects, and we supposed that it would vary with the source of
the experimental animals or the temperature of their
acclimation. However, neither the origin of the clams (New
England versus Florida) nor their acclimation temperature had
any effect upon potentiation.
Because potentiation was absent from July through October,
we expected that the sensitivity of branchial muscles to 5HT
would also be lowest in the late summer to early fall. In fact,
although the size of the responses to single doses of 5HT
(2×10–5·mol·l–1) are strongly seasonal, the largest occur in the
summer (compare Figs·4 and 13); and therefore, 5HT
dose–response curves constructed in the summer lie to the left
of those produced in the winter (Fig.·12). In contrast to the gill
muscle, the heart of Mercenaria is least sensitive to 5HT (by
about an order of magnitude) from late June through August
(Greenberg, 1960). Finally, we previously reported that the
lateral cilia of Mercenaria gills are less sensitive to inhibition
by dopamine from April to June (Gainey et al., 1999a). Thus,
although pharmacological seasonality is common, its timing
seems to vary from tissue to tissue.
The reproductive cycle of Mercenaria has been studied
extensively with respect to temperature and geography. Thus
spawning varies with water temperature, and there is a
latitudinal gradient, with Florida clams spawning in March
(and a second time in the fall) and New England clams
spawning once in August. But when Massachusetts and South
Carolina clams were crossed, a genetic component to the
spawning time was revealed. In addition, the time of spawning
could only be altered by a cyclic change in temperature, and
this procedure is effective only at certain times of the year
(Knaub and Eversole, 1988; for an extensive review, see
Eversole, 2001). Finally, potentiation and the other
neuropharmacological changes may be part of an endogenous
cycle. An amazing example of such a cycle was found in the
pulmonate Otala lactea. Gainer (1972) found that snails
in diapause, under constant laboratory conditions, would
spontaneously emerge in April, crawl about for several days,
and then return to a dormant state until the next April. These
complex phenomena indicate that there may well be
geographical or physiological differences in the seasonality of

potentiation and sensitivity that our experiments were unable
to resolve.
Nitric oxide mediates potentiation
Our experiments provide convincing evidence that
potentiation is mediated by NO. First, the NO donor DEANO
had, by itself, no effect on the gill muscle; i.e. the effects of
NO were only apparent after the muscle was stimulated with
5HT. Therefore, NO has no direct effect upon muscle
contraction. Second, when we pretreated gills with the NOS
inhibitor L-NAME, the response to a first dose of 5HT was
inhibited. Therefore, the initial exposure to 5HT generates NO,
which then potentiates the initial contraction. Finally, if LNAME was applied before the second dose of 5HT, the
resulting contraction was not potentiated. Therefore, NO must
be produced during both the first and the second contractions
if the second one is to be potentiated.
Signal transduction
Our results indicate that the effects of NO-mediated
potentiation are via the stimulation of sGC because
potentiation is inhibited by the SGC inhibitor ODQ in a dosedependent manner. Additionally, the cGMP analog dibutyryl
cGMP mimicked the effects of potentiation. In some systems,
e.g. vertebrate photoreceptors, cGMP interacts directly with
membrane ion channels, leading to a change in ionic
conductance, while in other systems the effects of cGMP
are elicited through stimulation of a PK-G, leading to
phosphorylation of target proteins (see references cited in the
Introduction). That the PK-G inhibitor RP-8-CPT-cGMPS
inhibited potentiation implies that potentiation is via the latter
pathway, i.e. stimulation of a PK-G.
Seasonality of NO mediation and signal transduction
The expression of immunoreactive NOS is seasonal, and the
pattern of seasonality is identical to that of potentiation. Thus,
in November, when potentiation occurs, NOS was clearly
present within the gill musculature; but in July and August,
during the off-season, NOS was not expressed in the muscle,
but appeared at the base of the gill filaments adjacent to the
muscle. The distance between the muscle and the base of the
filaments is about 25·µm, so NO can certainly diffuse into the
muscle. Moreover, when we pretreated gills with the NO
generator DEANO in July, there was no potentiation. Finally,
these observations are consistent with our observation that the
expression of immunoreactive sGC also varies seasonally; this
enzyme is not detectable in the muscle during the summer.
The mechanism of potentiation
Although we understand the basic signaling mechanism
involved in potentiation (Fig.·16), we do not totally understand
its underlying causes. Clearly NO modulates force production
in the gill musculature, but it is not clear how the initial
exposure to 5HT potentiates subsequent exposures to that
transmitter. Two sets of our experiments suggest that increased
activity of both NOS and sGC occurs following the initial
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Fig.·16. Model depicting the signal transduction events leading to
potentiation of gill muscle contraction. The coupling between the
5HT receptor is unknown, possibly via a G protein or the receptor
being part of a calcium channel. The presence of calcium channels is
inferred because the calcium channel blocker verapamil inhibits
contraction (L. F. Gainey, personal observation). The existence of a
neuronal-like NOS activated by calmodulin is based upon sequence
data (L. L. Moroz and B. Untch, personal communication). The
protein target(s) of phosphorylation by protein kinase G (PK-G) are
also unknown, but based upon data from other molluscs, the target
may be an L-type calcium channel, but the 5HT receptors or
contractile proteins may also be phosphorylated. –, enzyme
inhibitors; + stimulators; ?, uncertainty (also broken lines). CaM,
calmodulin; nNOS, neuronal-like nitric oxide synthase; NO, nitric
oxide; cGMP, cyclic GMP.

exposure to 5HT. In the experiments with the NOS inhibitor
potentiation was inhibited by 10–9·mol·l–1 L-NAME
during the initial exposure to 5HT. In contrast, a higher
concentration of L-NAME (10–6·mol·l–1) was needed to inhibit
potentiation during the second exposure to 5HT (compare
Figs·8 and 6, respectively). These experiments imply that there
is increased NOS activity during the second exposure to 5HT.
In the second set of analogous experiments with the sGC

L-NAME,

inhibitor ODQ, potentiation was inhibited by 10–5·mol·l–1
ODQ during the initial exposure to 5HT. In contrast, we could
not completely inhibit potentiation with 10–4·mol·l–1 ODQ
during the second exposure to 5HT (compare Figs·13 and 12,
respectively). Again, there is an implication of increased sGC
activity during the second exposure to 5HT. These data do not
preclude changes in the activity of PK-G, phsophodiesterases
or protein phosphatases.
We speculate that increased concentrations of cGMP,
resulting from increases in the activity of NOS and sGC, lead
to an increased influx of calcium through phosphorylated
membrane channels in response to the second dose of 5HT,
resulting in potentiation. There are several studies in Lymnaea
showing that the effects of 5HT are mediated by cGMPdependent phosphorylation of calcium channels. Moreover, in
Helix, modulation of calcium currents in neuron F1 is via
regulation of a phosphorylation/dephosphorylation cycle of
calcium channels (for a summary of data for both Lymnaea and
Helix, see Kits and Mansvelder, 1996). Although we know the
seasonal patterns of expression of both NOS and sGC, we have
not yet measured changes in the activity of any of the relevant
enzymes.
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